Stephen L. von Rump is CEO / CFO at Medite Cancer Diagnostics, Inc. (MDIT). They have made 1 open-market trade across 1 company since 2018, most recently 2018-07-27.
CIK 0001740138
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $11K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDIT | 266,666 | — |
Shares reported on the most recent Form 4, priced at the 2018-07-30 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDIT | BUY | 2018-07-27 | 2018-07-30 | $0.08 | $11K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.